Novozymes wins Chinese patent case after protracted court battle

The Supreme People's Court of China has ruled in favor of Novozymes in a case against two Chinese companies.

Photo: Novozymes/ PR

The Danish producer of enzymes and microorganisms Novozymes has won a patent case in China which thus marks the end of a court battle which has been ongoing for the past five-six years, writes Novozymes in a press release.

The case began in 2011 when Novozymes found evidence that the two companies, Shandong Longda Bio-Products and Jiangsu Boli Bioproducts, were selling an enzyme for which Novozymes had Chinese patent protection.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Equinor exits Russia

Norwegian oil company Equinor has taken its final step out of the Russian market by transferring joint venture assets to Rosneft.

Ørsted aims to be number one on carbon capture

The utility hopes to win the Danish carbon capture and storage tender with a plan to capture 400,000 tonnes of CO2 by 2025 from the company’s biomass-fired combined heat and power stations.

Further reading

Related articles

Latest News

See all jobs